PTK2B, a well-known AD gene with high expression in brain (z-score = 0.90), was identified as an early marker and in vivo modulator of tau pathology [65], by mediating Aβ-induced synaptic dysfunction and loss [66]. This evidence concerns the gene MAPT and Alzheimer disease.